Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Emergency Medicine
Volume 2017, Article ID 4289527, 3 pages
Case Report

Physician Beware: Severe Cyanide Toxicity from Amygdalin Tablets Ingestion

1Department of Emergency Medicine, Corona Regional Medical Center, Corona, CA, USA
2Department of Pharmacy, University of California Irvine, Orange, CA, USA
3Department of Hematology and Oncology, Genesis Cancer Center, Zanesville, OH, USA

Correspondence should be addressed to Phu N. Tran; gro.schsiseneg@nartp

Received 4 April 2017; Accepted 26 July 2017; Published 24 August 2017

Academic Editor: Vasileios Papadopoulos

Copyright © 2017 Tam Dang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Despite the risk of cyanide toxicity and lack of efficacy, amygdalin is still used as alternative cancer treatment. Due to the highly lethal nature of cyanide toxicity, many patients die before getting medical care. Herein, we describe the case of a 73-year-old female with metastatic pancreatic cancer who developed cyanide toxicity from taking amygdalin. Detailed history and physical examination prompted rapid clinical recognition and treatment with hydroxocobalamin, leading to resolution of her cyanide toxicity. Rapid clinical diagnosis and treatment of cyanide toxicity can rapidly improve patients’ clinical outcome and survival. Inquiries for any forms of ingestion should be attempted in patients with clinical signs and symptoms suggestive of poisoning.